Trial reportFrontiers in endocrinology2025
A study on the clinical effectiveness of a tiered management model for type 2 diabetes based on a three-level linkage mechanism in the context of residency training: a randomized controlled trial.
Trial report in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: With the widespread implementation of General Practice Residency Training (GPRT) in China, primary care institutions have enhanced chronic disease management capabilities. However, research on tiered management for type 2 diabetes mellitus (T2DM), particularly systematic exploration based on a three-tier collaborative model (primary-secondary-tertiary institutions), remains limited. Objective: To evaluate the clinical effectiveness of a three-tiered linkage hierarchical management model for T2DM implemented within the GPRT framework. Methods: This study enrolled 120 T2DM patients from a community-based GPRT site (followed February-November 2024). Stratified by clinical risk factor, patients were randomly assigned (computer-generated sequence, allocation concealed) to an intervention group (n=60) or control group (n=60). The intervention group received tiered management via an"Internet+"platform(telemedicine)coordinated by multidisciplinary teams (general practice residents, mentors, specialists). The control group received standard community care. Fasting blood glucose (FPG), 2-hour postprandial blood glucose (2h-PBG), glycated hemoglobin (HbA1c), and the Summary of Diabetes Self-Care Activities (SDSCA) scale were assessed at baseline, 3, and 6 months. Results: Baseline characteristics, FPG, 2h-PBG, and HbA1c were comparable (P > 0.05). Post-intervention, the intervention group exhibited significantly greater reductions in FPG, 2h-PBG, and HbA1c than the control group (P < 0.05). SDSCA scores indicated superior improvements in key domains (diet, exercise, blood glucose monitoring, foot care) for the intervention group (P < 0.05). Medium- and high-risk subgroups within the intervention group achieved significantly better glycemic control than their control counterparts (P < 0.05), with no significant difference observed in the low-risk subgroup (P > 0.05). Conclusion: The three-tiered linkage management model under GPRT significantly improves glycemic control and self-management in T2DM patients. Integrating multidisciplinary teamwork and digital tools, the model's structure demonstrates effectiveness within the community setting and exhibits potential for wider implementation in broader healthcare contexts, offering valuable policy implications for optimizing chronic disease management. Clinical Trial Registration: https://www.chictr.org.cn/index.html, identifier ChiCTR2500100827.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.